Chemotherapies, e.g. gemcitabine have also been found to increase Nrf2 expression, while pretreatment with Nrf2 inhibitors enhances the sensitivity of PC cells to chemotherapy [108]. The gene discussed is NFE2L2; the disease is pachyonychia congenita.